Conferral of an antiviral state to CD4+ cells by a zipper motif envelope mutant of the human immunodeficiency virus type 1 transmembrane protein gp41

Human Gene Therapy

Volumn 10, Issue 14, 1999, Pages 2381-2395

  Chuang, C K ^a   Lee, S F ^a   Chen, S S L ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; ENVELOPE PROTEIN; GLYCOPROTEIN GP 41; MEMBRANE PROTEIN; PLASMID DNA; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSMISSION;

CD4-POSITIVE T-LYMPHOCYTES; CYTOPATHOGENIC EFFECT, VIRAL; CYTOTOXICITY, IMMUNOLOGIC; HELA CELLS; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; LEUCINE ZIPPERS; MICROSCOPY, FLUORESCENCE; MUTATION; RECOMBINANT PROTEINS; TRANSFECTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033588947     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017031     Document Type: Article

References (56)

1. ABACIOGLU, Y.H., FOUTS, T.R., LAMAN, J.D., CLAASEN, E., PINCUS, S.H., MOORE, J.P., ROBY, C.A., KAMIN-LEWIS, R., and LEWIS, G.K. (1994). Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res. Hum. Retroviruses 10, 371-381.
2. ADACHI, A., GENDELMAN, H.E., KOENIG, S., FOLKS, T., WILLEY, R., RABSON, A., and MARTIN, M.A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291.
3. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K. (1995). Current Protocols in Molecular Biology. (John Wiley & Sons, New York).
4. BANDA, N.K., BERNIER, J., KURAHARA, D.K., KURRLE, R., HAIGWOOD, N., SEKALY, R.-P., and FINKEL, T.H. (1992). Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176, 1099-1106.
5. BERGER, E.A. (1997). HIV entry and tropism: The chemokine receptor connection. AIDS 11(Suppl.), S3-S16.
6. BERNSTEIN, H.B., TUCKER, S.P., KAR, S.R., McPHERSON, S.A., McPHERSON, D.T., DUBAY, J.W., LEBOWITZ, J., COMPANS, R.W., and HUNTER, E. (1995). Oligomerization of the hydrophobic heptad repeat of gp41. J. Virol. 69, 2745-2750.
7. BINLEY, J., and MOORE, J.P. (1997). The viral mousetrap. Nature (London) 387, 346-348.
8. BLACKLOW, S.C., LU, M., and KIM, P.S. (1995). A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry 34, 14955-14962.
9. BUCHSCHACHER, G.L., JR., FREED, E.O., and PANGANIBAN, A.T. (1992). Cells induced to express a human immunodeficiency virus type 1 envelope gene mutant inhibit the spread of wild-type virus. Hum. Gene Ther. 3, 391-397.
10. BULLOUGH, P.A., HUGHSON, F.M., SKEHEL, J.J., and WILEY, D.C. (1994). Structure of influenza hemagglutinin at the pH of membrane fusion. Nature (London) 371, 37-43.
11. CARR, C.M., and KIM, P.S. (1993). A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73, 823-832.
12. CENTER, R.J., KEMP, B.E., and POUMBOURIOS, P. (1997). Human immunodeficiency virus type 1 and 2 envelope glycoproteins oligomerize through conserved sequences. J. Virol. 71, 5706-5711.
13. CHAN, D.C., FASS, D., BERGER, J.M., and KIM, P.S. (1997). Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273.
14. CHEN, C.-H., MATTHEWS, T.J., McDANAL, C.B., BOLOGNESI, D.P., and GREENBERG, M.L. (1995). A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: Implication for viral function. J. Virol. 69, 3771-3777.
15. CHEN, S.S.-L. (1994). Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 68, 2002-2010.
16. CHEN, S.S.-L., LEE, C.-N., LEE, W.-R., McINTOSH, K. and LEE, T.-H. (1993). Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J. Virol. 67, 3615-3619.
17. CHEN, S.S.-L., FERRANTE, A.A., and TERWILLIGER, E.F. (1996). Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity. Virology 226, 260-268.
18. CHEN, S.S.-L., LEE, S.-F., HAO, H.-J., and CHUANG, C.-K. (1998). Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interferes with the wild-type virus infectivity. J. Virol. 72, 4765-4774.
19. + cells by an envelope double mutant. J. Virol. (in press).
20. DUBAY, J.W., ROBERTS, S.J., BRODY, B., and HUNTER, E. (1992). Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 66, 4748-4756.
21. FASS, D., and KIM, P.S. (1995). Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin. Curr. Biol. 5, 1377-1383.
22. FASS, D., HARRISON, S.C., and KIM, P.S. (1996). Retrovirus envelope domain at 1.7 Å resolution. Nature Struct. Biol. 3, 465-469.
23. FREED, E.O., DELWART, E.L., BUCHSCHACHER, G.L., JR., and PANGANIBAN, A.T. (1992). A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. U.S.A. 89, 70-74.
24. GABUZDA, D.H., LEVER, A., TERWILLIGER, E., and SODROSKI, J. (1992). Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 66, 3306-3315.
25. HERNANDEZ, L.D., HOFFMAN, L.R., WOLFSBERG, T.G., and WHITE, M. (1996). Virus-cell and cell-cell fusion. Annu. Rev. Dev. Biol. 12, 627-661.
26. HUGHSON, P.M. (1997). Enveloped viruses: A common mode of membrane fusion? Curr. Biol. 7, R565-R569.
27. JIANG, S., LIN, K., STRICK, N., and NEURATH, A.R. (1993). HIV-1 inhibition by a peptide. Nature (London) 365, 113.
28. JONES, P.L.S.J., KORTE, T., and BLUMENTHAL, R. (1998). Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface and co-receptors. J. Biol. Chem. 273, 404-408.
29. JUDICE, J.K., TOM, J.Y.K., HUANG, W., WRIN, T., VENNARI, J., PETROPOULOS, C.J., and McDOWELL, R.S. (1997). Inhibition of HIV type 1 infectivity by constrained α-helical peptides: Implications for the viral fusion mechanism. Proc. Natl. Acad. Sci. U.S.A. 94, 13426-13430.
30. KIMPTON, J., and EMERMAN, M. (1992). Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66, 2232-2239.
31. KOLESNITCHENKO, V., WAHL, L.M., TIAN, H., SUNILA, I., TANI, Y., HARTMANN, D.P., COSSMAN, J., RAFFELD, M., OREENSTEIN, J., SAMELSON, L.E., and COHEN, D.I. (1995). Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death. Proc. Natl. Acad. Sci. U.S.A. 92, 11889-11893.
32. KOLESNITCHENKO, V., KING, L., RIVA, A., TANI, Y., KORSMEYER, S.J., and COHEN, D.J. (1997). A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis. J. Virol. 71, 9753-9763.
33. LAWLESS, M.K., BARNEY, S., GUTHRIE, K.L., BUCY, T.B., PETTEWAY, S.R., JR., and MERUTKA, G. (1996). HIV-1 membrane fusion mechanism: Structural studies of the interactions between biologically active peptides from gp41. Biochemistry 35, 13697-13708.
34. LIPSKY, J.J. (1996). Antiretroviral drugs for AIDS. Lancet 348, 800-803.
35. LU, M., BLACKLOW, S.C., and KIM, P.S. (1995). A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Struct. Biol. 2, 1075-1082.
36. MATTHEWS, T.J., WILD, C., CHEN, C-H., BOLOGNESI, D.P., and GREENBERG, M.L. (1994). Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol. Rev. 140, 93-104.
37. MOORE, J., and TRKOLA, A. (1997). HIV-1 type 1 coreceptors, neutralization serotypes, and vaccine development. AIDS Res. Hum. Retroviruses 13, 733-736.
38. MOORE, J.P., JAMESON, B.A., WEISS, R.A., and SATTENTAU, Q.J. (1993). The HIV-Cell Fusion Reaction. (CRC Press, Boca Raton, FL).
39. POUMBOURIOS, P., AHMAR, W.E., McPHEE, D.A., and KEMP, B.E. (1995). Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure. J. Virol. 69, 1209-1218.
40. POUMBOURIOS, P., WILSON, K.A., CENTER, R.J., AHMAR, W.E., and KEMP, B.E. (1997). Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic α-helical/leucine zipper-like sequence. J. Virol. 71, 2041-2049.
41. RABENSTEIN, M., and SHIN, Y.-K. (1995). A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Biochemistry 34, 13390-13397.
42. RABENSTEIN, M.D., and SHIN, Y.-K. (1996). HIV-1 gp41 tertiary structure studied by EPR spectroscopy. Virology 35, 13922-13928.
43. SHUGARS, D.C., WILD, C.T., GREENWELL, T.K., and MATTHEWS, T.J. (1996). Biophysical characterization of recombinant proteins expressing the leucine zipper-like domain of the human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 70, 2982-2991.
44. STEFFY, K.R., and WONG-STAAL, F. (1993). Transdominant inhibition of wild-type human immunodeficiency virus type 2 replication by an envelope deletion mutant. J. Virol. 67, 1854-1859.
45. TAN, K., LIU, J.-H., WANG, J.-H., SHEN, S., and LU, M. (1997). Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl. Acad. Sci. U.S.A. 94, 12303-12308.
46. TRUJILLO, J.R., WANG, W.K., LEE, T.-H., and ESSEX, M. (1996). Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1. Virology 217, 613-617.
47. WEISSENHORN, W., WHARTON, S.A., CALDER, L.J., EARL, P.L., MOSS, B., ALIPRANDIS, E., SKEHEL, J.J., and WILEY, D.C. (1996). The ectodomain of HIV-1 Env subunit gp41 forms a soluble, α-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO J. 15, 1507-1514.
48. WEISSENHORN, W., CALDER, L., DESSEN, A., LAUE, T., SKEHEL, J.J., and WILEY., D.C. (1997a). Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 94, 6065-6069.
49. WEISSENHORN, W., DESSEN, A., HARRISON, S.C., SKEHEL, J.J., and WILLEY, D.C. (1997b). Atomic structure of the ecdodomain from HIV-1 gp41. Nature (London) 387, 426-430.
50. WESTERVELT, P., GENDELMAN, H.E., and RATNER, L. (1991). Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes. Proc. Natl. Acad. Sci. U.S.A. 88, 3097-3101.
51. WHITE, J.M. (1992). Membrane fusion. Science 258, 917-924.
52. WILD, C., OAS, T., McDANAL, C., BOLOGNESI, D., and MATTHEWS, T. (1992). A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. J. Virol. 89, 10537-10541.
53. WILD, C., DUBAY, J.W., GREENWELL, T., BAIRD, J., OAS, T.G., McDANAL, C., HUNTER, E., and MATTHEWS, T. (1994a). Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. U.S.A. 91, 12676-12680.
54. WILD, C. SHUGARS, D.C., GREENWELL, T.K., McDONAL, C.B., and MATTHEWS, T.J. (1994b). Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. U.S.A. 91, 9770-9774.
55. WILD, C., GREENWELL, T., SHUGARS, D., RIMSKY-CLARKE, L., and MATTHEWS, T. (1995). The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res. Hum. Retroviruses 11, 323-325.
56. WILSON, I.A., SKEHEL, J.J., and WILEY, D.C. (1981). Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3Å resolution. Nature (London) 289, 366-373.